BRWA
GSK icon

B. Riley Wealth Advisors’s GSK GSK Stock Holding History

B. Riley Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Buy
8,133
+23
+0.3% +$1.22K 0.02% 511
2026
Q1 		$440K Sell
8,110
-5,577
-41% -$302K 0.03% 468
2025
Q4 		$671K Sell
13,687
-2,759
-17% -$129K 0.03% 437
2025
Q3 		$710K Sell
16,446
-4,628
-22% -$181K 0.03% 424
2025
Q2 		$809K Buy
+21,074
New +$805K 0.04% 397
2024
Q4 		$867K Sell
25,346
-5,492
-18% -$198K 0.03% 499
2024
Q3 		$1.23M Sell
30,838
-7,633
-20% -$312K 0.03% 443
2024
Q2 		$1.5M Sell
38,471
-10,324
-21% -$434K 0.04% 417
2024
Q1 		$1.79M Buy
48,795
+6,348
+15% +$262K 0.05% 384
2023
Q4 		$1.59M Sell
42,447
-6,348
-13% -$228K 0.04% 410
2023
Q3 		$1.79M Buy
48,795
+7,420
+18% +$263K 0.05% 384
2023
Q2 		$1.49M Sell
41,375
-883
-2% -$31.7K 0.03% 454
2023
Q1 		$1.52M Buy
42,258
+1,477
+4% +$51.7K 0.04% 429
2022
Q4 		$1.44M Buy
40,781
+5,606
+16% +$187K 0.04% 429
2022
Q3 		$1.04M Buy
35,175
+5,189
+17% +$197K 0.03% 498
2022
Q2 		$1.63M Sell
29,986
-4,108
-12% -$227K 0.07% 287
2022
Q1 		$1.86M Buy
34,094
+2,253
+7% +$122K 0.06% 316
2021
Q4 		$1.76M Buy
31,841
+1,963
+7% +$102K 0.05% 384
2021
Q3 		$1.43M Sell
29,878
-1,568
-5% -$78.8K 0.05% 416
2021
Q2 		$1.56M Sell
31,446
-3,907
-11% -$188K 0.05% 396
2021
Q1 		$1.58M Buy
35,353
+7,146
+25% +$324K 0.06% 364
2020
Q4 		$1.3M Sell
28,207
-29,786
-51% -$1.37M 0.07% 268
2020
Q3 		$2.79M Buy
57,993
+16,603
+40% +$832K 0.15% 156
2020
Q2 		$2.11M Sell
41,390
-983
-2% -$50.4K 0.14% 163
2020
Q1 		$2.01M Buy
42,373
+21,069
+99% +$1.12M 0.17% 138
2019
Q4 		$1.25M Sell
21,304
-4,865
-19% -$271K 0.11% 205
2019
Q3 		$1.4M Buy
26,169
+171
+0.7% +$8.8K 0.14% 171
2019
Q2 		$1.3M Buy
25,998
+1,840
+8% +$92.3K 0.14% 153
2019
Q1 		$1.26M Buy
24,158
+676
+3% +$33.8K 0.16% 146
2018
Q4 		$1.12M Sell
23,482
-844
-3% -$41.6K 0.16% 138
2018
Q3 		$1.22M Sell
24,326
-1,251
-5% -$63.6K 0.15% 158
2018
Q2 		$1.29M Sell
25,577
-41
-0.2% -$2.06K 0.17% 146
2018
Q1 		$1.25M Sell
25,618
-19,420
-43% -$904K 0.18% 137
2017
Q4 		$2M Buy
+45,038
New +$2.08M 0.27% 101
2017
Q3 		– Sell
-43,492
Closed -$2.35M – 562
2017
Q2 		$2.35M Sell
43,492
-278
-0.6% -$14.8K 0.43% 55
2017
Q1 		$2.31M Buy
43,770
+1,559
+4% +$79.1K 0.46% 51
2016
Q4 		$2.03M Sell
42,211
-2,393
-5% -$118K 0.41% 57
2016
Q3 		$1.38M Sell
44,604
-1,279
-3% -$70.1K 0.27% 94
2016
Q2 		$1.42M Buy
+45,883
New +$2.42M 0.28% 83
2016
Q1 		– Sell
-21,622
Closed -$1.09M – 577
2015
Q4 		$1.09M Sell
21,622
-6,097
-22% -$311K 0.22% 121
2015
Q3 		$1.33M Buy
27,719
+3,695
+15% +$192K 0.32% 73
2015
Q2 		$1.25M Sell
24,024
-1,103
-4% -$62.1K 0.31% 78
2015
Q1 		$1.45M Sell
25,127
-16,346
-39% -$937K 0.35% 66
2014
Q4 		$12.6K Buy
41,473
+25,539
+160% +$1.43M 0.27% 71
2014
Q3 		$916K Sell
15,934
-3,556
-18% -$218K 0.24% 107
2014
Q2 		$664K Buy
19,490
+13,483
+224% +$913K 0.16% 145
2014
Q1 		$401K Buy
6,007
+934
+18% +$63.1K 0.12% 192
2013
Q4 		$339K Sell
5,073
-179
-3% -$11.6K 0.11% 213
2013
Q3 		$329K Buy
5,252
+714
+16% +$46K 0.11% 206
2013
Q2 		$283K Buy
+4,538
New +$288K 0.1% 242

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

B. Riley Wealth Advisors's GSK Position: Q2 2026 in Review

B. Riley Wealth Advisors increased its GSK (GSK) stake by 0.28% in Q2 2026, buying an estimated $1.22K and bringing the position to 8,133 shares worth $429K. The position accounts for 0.02% of the portfolio, ranked #511.

B. Riley Wealth Advisors first reported a position in GSK in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.79M in Q3 2020. 210 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • B. Riley Wealth Advisors held 8,133 shares of GSK worth $429K as of Q2 2026.
  • B. Riley Wealth Advisors bought 23 GSK shares in Q2 2026, an estimated $1.22K.
  • GSK made up 0.02% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #511 holding.
  • B. Riley Wealth Advisors first reported a position in GSK in Q2 2013 and has held it in 50 quarters since.
  • B. Riley Wealth Advisors's GSK position peaked at $2.79M in Q3 2020.
  • 210 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.